Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Global demand for Orthostatic Hypotension Drugs Market was valued at approximately USD 560.93 Million in 2018, and is expected to generate revenue of around USD 978.45 Million by end of 2025, growing at a CAGR of around 8.34% between 2018 and 2025.

02-Dec-2019 | Number of pages: 110 | Report Code: ZMR-5123 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthostatic Hypotension Drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Orthostatic Hypotension Drugs market on a global level. In order to give the users of this report a comprehensive view on the Orthostatic Hypotension Drugs market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Diagnostic Test Type, Drug Type, End user, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

According to the report, global demand for Orthostatic Hypotension Drugs Market was valued at approximately USD 560.93 Million in 2018, and is expected to generate revenue of around USD 978.45 Million by end of 2025, growing at a CAGR of around 8.34% between 2018 and 2025.

The prevalence of neurodegenerative diseases, cardiovascular diseases, and diabetes is increasing worldwide significantly, increasing the risk of Orthostatic hypotension. It is associated with a neurological disorder underlying autonomy. Dehydration is also a common condition in individuals that increases the risk of Orthostatic hypotension and causes nerve damage. This growth in the prevalence of chronic diseases associated with high risk of Orthostatic hypotension would result in the expansion of the global market for orthostatic hypotension drugs in the forecast period.

The study provides a decisive view on the Orthostatic Hypotension Drugs market by segmenting the market based on Diagnostic Test Type, Drug Type, End user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on Diagnostic Test Type, the market is segmented into ECG, Blood Tests, Stress Test and Other. Based on the Drug Type segment, the market is bifurcated Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others. The midodrine group showed the largest market share of orthostatic hypotension drugs in 2018. Nonetheless, by the end of the forecast period, the Northera (droxidopa) segment will grow faster and emerge as the market leader. Based on the End user segment, the market is bifurcated into Hospitals, ASCs and Clinics and Others.

The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. During the forecast period, North America will account for the largest market share of Orthostatic hypotension products. Factors such as high pharmaceutical expenditure per person, strong market presence of leading manufacturers, access to advanced healthcare, and increased awareness of Orthostatic hypotension contribute to the growth of this region's orthostatic hypotension drug market.

Orthostatic hypotension is a chronic debilitating disease that in several cases is difficult to treat. When treating orthostatic hypotension patients, single drug therapy may not be appropriate as orthostatic pressure varies with daytime circumstances. This has contributed to a growing emphasis on using combination therapy in orthostatic hypotension therapy. It is predicted that this innovation will have a positive impact on overall market growth. The prevalence of neurodegenerative diseases, cardiovascular diseases and diabetes is growing dramatically worldwide, raising the risk of Orthostatic hypotension. It is associated with an independent neurological disorder that underlies this. Dehydration is also a common condition in individuals which increases the risk of Orthostatic hypotension and causes nerve damage. This increase in the prevalence of chronic diseases associated with high risk of Orthostatic hypotension will result in the expansion of the global market for orthostatic hypotension drugs in the forecast period.

Key players within global Orthostatic Hypotension Drugs market include Amneal Pharmaceuticals Inc., H. Lundbeck AS, Mylan NV, Novartis AG and Pfizer Inc. amongst others.

The report segments global Orthostatic Hypotension Drugs market as follows:

Global Orthostatic Hypotension Drugs Market: Diagnostic Test Type Segment Analysis

  • ECG
  • Blood Tests
  • Stress Test
  • Other

Global Orthostatic Hypotension Drugs Market: Drug Type Segment Analysis

  • Midodrine
  • Northera (droxidopa)
  • Fludrocortisone
  • Caffeine
  • Others

Global Orthostatic Hypotension Drugs Market: End user Segment Analysis

  • Hospitals
  • ASCs and Clinics
  • Others

 Global Orthostatic Hypotension Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Macular Degeneration Treatment Market: by Drug Class (Anti-VEGFs and Other Drugs); by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)); by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5117 | Report Format:

The report covers forecast and analysis for the macular degeneration treatment market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the macular degenerat...Read More

Plantar Fasciitis Treatment Market: by Type (Medication Therapy [Oral, and Parenteral], Orthotics, Shockwave Therapy [Extracorporeal Shock Wave Therapy, and Intracorporeal Pneumatic Shockwave Therapy], Surgery, and Others), and by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5116 | Report Format:

According to the report, global demand for plantar fasciitis treatment market was valued at USD 603.3 million in 2018, and is expected to generate revenue of USD 2,469.1 million by end of 2025, growing at a CAGR of 22.3% between 2019 and 2025 The report covers forecast and analysis for the globa...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.